Related Experiment Videos
Leukocyte collagenolytic activity in normal and hydrazinophthalazine-treated rats during isoprenaline-induced
Insights
Isoprenaline-induced cardiomyopathy in rats revealed differing enzyme activity changes between healthy and hydrazinophthalazine-treated groups. Hydrazinophthalazine treatment showed a negative synergistic effect with isoprenaline on cardiac enzymes and morphology.
Area of Science:
- Biochemistry
- Cardiology
- Pharmacology
Background:
- Cardiomyopathy is a significant cardiac condition.
- Isoprenaline is a known agent for inducing experimental cardiomyopathy.
- Hydrazinophthalazine is a drug with potential cardiovascular effects.
Purpose of the Study:
- To investigate the impact of hydrazinophthalazine on isoprenaline-induced cardiomyopathy in rats.
- To analyze the activity of leukocyte collagenase and collagenolytic cathepsin during cardiomyopathy development.
- To evaluate the morphological changes in heart muscle tissue.
Main Methods:
- Cardiomyopathy was induced using isoprenaline injections in rats.
- Rats were either healthy or pre-treated with hydrazinophthalazine.
- Leukocyte collagenase and collagenolytic cathepsin activity were measured at specific time points post-injection.
- Morphological studies of cardiac muscle were conducted concurrently.
Main Results:
- Enzyme activity alterations differed significantly between healthy and hydrazinophthalazine-treated rats.
- A negative synergistic interaction between isoprenaline and hydrazinophthalazine was observed.
- Biochemical and morphological findings supported this observed synergism.
Conclusions:
- Hydrazinophthalazine modifies the biochemical and morphological response to isoprenaline-induced cardiomyopathy.
- The study highlights a negative synergistic effect, suggesting potential drug interactions in cardiac conditions.
Abstract:
Cardiomyopathy was produced by isoprenaline injections to healthy and hydrazinophthalazine-treated rats. The activity of leukocyte collagenase and collagenolytic cathepsin was determined on the 2nd, 7th, 19th and 21st day after the last isoprenaline injection. At the same time morphological studies of the heart muscles were carried out. It was found that alterations in enzyme activity were different in healthy and hydrazinophthalazine-treated rats. A negative synergism of isoprenaline as regards the hydrazinophthalazine action was observed in biochemical and morphological studies.